Lukas Biomedical Inc. (TPEX:6814)
Taiwan · Delayed Price · Currency is TWD 24.60
-0.70 (-2.77%)
Jul 14, 2026, 12:50 PM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 1.03 billion as of July 14, 2026. Its market cap has increased by 7.19% in one year.
Market Cap
1.03B
Enterprise Value
1.15B
Revenue
179.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.60
Market Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 1.03B, a decrease of -41.97%. That is a compound annual growth rate of -9.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.03B | -20.65% |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.24B |
| Enimmune | 1.20B |
| BiOptic | 1.16B |
| LabTurbo Biotech | 1.11B |
| Bio Preventive Medicine | 1.07B |
| Level Biotechnology | 1.04B |
| Holy Stone Healthcare | 1.03B |
| TCI GENE | 978.96M |